20 Oct 2022 --- Kirin Holdings is expanding its functional food product lineup to increase immune care in Japan. In collaboration with external partner companies, Kirin Holdings will increase immune function claims and the number of products containing its exclusive postbiotic Lactococcus lactis strain Plasma (L. lactis strain Plasma). “By joining forces with partner companies in various industries, we can dramatically expand consumer touchpoints. By combining B2B and B2C businesses, we will penetrate the immune care market, which is the foundation of health management and contribute to a healthy society,” Tatsuya Takada, manager at Kirin Holdings Corporate Communications Department, tells NutritionInsight.
